An open label study to evaluate the safety and reduction in signs and symptoms during treatment with tocilizumab in patients with moderate to severe active rheumatoid arthritis
Phase of Trial: Phase III
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- 16 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 10 Aug 2010 Status changed from active, no longer recruiting to completed as reported by Roche.
- 20 Jun 2009 New source identified and integrated (Roche, ML22074).